Related references
Note: Only part of the references are listed.Quality and Safety Requirements for Sustainable Phage Therapy Products
Jean-Paul Pirnay et al.
PHARMACEUTICAL RESEARCH (2015)
Call for a Dedicated European Legal Framework for Bacteriophage Therapy
Gilbert Verbeken et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2014)
A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens
Xavier Wittebole et al.
VIRULENCE (2014)
Bacteriophage therapy of venous leg ulcers in humans: results of a phase I safety trial
D.D. Rhoads et al.
Journal of Wound Care (2014)
Phage cocktails and the future of phage therapy
Benjamin K. Chan et al.
FUTURE MICROBIOLOGY (2013)
Optimizing the European Regulatory Framework for Sustainable Bacteriophage Therapy in Human Medicine
Gilbert Verbeken et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2012)
Factors associated with success of market authorisation applications for pharmaceutical drugs submitted to the European Medicines Agency
Jan Regnstrom et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
A controlled clinical trial of a therapeutic bacteriophage preparation in chronic otitis due to antibiotic-resistant Pseudomonas aeruginosa; a preliminary report of efficacy
A. Wright et al.
CLINICAL OTOLARYNGOLOGY (2009)
Utilization of target-specific, hypersensitive strains of Saccharomyces cerevisiae to determine the mode of action of antifungal compounds
ET Buurman et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Bacteriophage therapy
A Sulakvelidze et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Share Paper
